Current approaches and future directions in the management of pterygium

Abstract

Pterygium, a common ocular surface disorder, has a complex pathophysiology that may mimic tumorigenesis. There is altered expression of cell cycle/proliferation-related factors in pterygium tissues. Therefore, similar to cancer treatments, the management of pterygium ought to be multifactorial based on the patient's condition. Current therapeutic methods for pterygium are focused on surgical resection in conjunction with antimetabolite use, in addition tissue graft is usually performed in the context of the avoidance of bare sclera. However, future directions in the management of pterygia will likely focus on genetic approaches. This perspective views the pathogenesis of pterygium, its existing therapies as well as current and future challenges in its treatment.

Keywords: future directions; pterygium; recurrence; tumor.

Figures

Figure 1. Severe cases of pterygium complicated by symblepharon, severe hypervascularization, motility restriction-related diplopia and impaired vision.